Posts Tagged ‘IBB’

Options Active In Biotechnology Space

 

Today’s tickers: IBB, AMAG & AONE

IBB - iShares Nasdaq Biotechnology Index Fund – Shares in the IBB, an ETF that tracks the performance of the NASDAQ Biotechnology Index, an index containing securities of companies classified as either biotechnology or pharmaceuticals, are outperforming the S&P 500 this morning, up 0.40% at $112.73 as of 11:30 a.m. in New York. The Fund’s shares are slightly off their all-time high of $114.87 set last Thursday, and options activity on the ETF today suggests one strategist may be locking in recent gains ahead of a spate of earnings releases from companies in the Index. The top 10 holdings represent more than 50% of the total Index. Amgen, Inc. and Celgene Corp. are the two largest holdings, comprising approximately 8.8% and 6.6%, respectively. Both companies are scheduled to report earnings this Thursday. The strategist responsible for the single largest transaction in IBB options today may be hedging a long position in the index or components, or may be taking an outright bearish stance on the biotech and pharmaceuticals space during earnings season. The trader appears to have sold around 4,500 calls at the Mar. $115 strike in order to partially finance the purchase of a 4,500-lot Mar. $107/$112 put spread, all for a net premium outlay of $0.05 per contract. The sale of the call options greatly reduced the cost of the put spread, which may yield profits – or downside protection – to the investor in the event that shares in the IBB dip 0.70% to breach the effective breakeven price of $111.95. Maximum potential profits of $4.95 per contract are available on the position should shares drop 5.1% to settle at or below $107.00 at expiration. The short calls, if uncovered, could result in losses on the trade in the event that the Fund’s shares rally to new record highs by expiration in March.…
continue reading


Tags: , ,




Bullish Smoke Signals Detected at Human Genome Sciences

Today’s tickers: HGSI, BSX, DFS, CSCO, LVLT, AMGN & IBB

HGSI - Human Genome Sciences, Inc. – Shares in Human Genome Sciences are up 8.9% to trade around $26.49 in the final hour of the trading session on speculation the firm could become an attractive takeover target if its lupus drug treatment, Benlysta, wins approval next month. Options traders sent up a number of bullish signals using January 2011 contract call and put options. Earlier this morning, one optimistic investor initiated a debit call spread, buying 3,000 calls at the January 2011 $27 strike for a premium of $3.90 each, and selling the same number of calls at the higher January 2011 $40 strike at a premium of $0.375 apiece. The net cost of putting on the spread amounts to $3.525 per contract. The investor makes money on the spread if Human Genome’s shares surge 15.2% over the current price of $26.49 to exceed the effective breakeven point at $30.525 by January expiration. The call spreader could end up taking home maximum potential profits of $9.475 per contract if the price of the underlying stock jumps 51.0% to trade above $40.00 by expiration day next year. The trader is well positioned to benefit from the rally in HGSI shares that would accompany Benlysta’s approval and/or continued takeover chatter. Another bullish sign that appeared in the same expiry involved put options. It looks like another investor unraveled a previously established bear put spread, selling 2,750 puts at the Jan. 2011 $20 strike and buying the same number of puts at the lower Jan. 2011 $15 strike, to take in a net premium of $1.25 per contract. It is possible the transaction is an opening credit put spread rather than a closing sale, but open interest levels at both strikes are more than sufficient to cover today’s volume. Either way, the trade is another sign of optimism on the biotechnology company ahead of the key drug approval decision. Options implied volatility on the stock is…
continue reading


Tags: , , , , , ,




Put Butterfly Spread on Financials ETF Points to Persisting Pessimism

Today’s tickers: XLF, CMCSA, IBB, IYR, KBE & RIG

XLF – Financial Select Sector SPDR ETF – Investors heavily favored put options over call options on the financial SPDR today despite the 4.4% rebound in the price of the underlying stock to $15.75. Earlier in the trading session shares of the XLF, an exchange-traded fund seeking investment results that correspond to the price and yield performance of the Financial Select Sector of the S&P 500 Index, increased 6.15% over Friday’s closing price of $15.09 to reach an intraday high of $16.02 in the first 30 minutes of the session. Options traders populating the fund today initiated decidedly bearish transactions signaling shares of the fund may be unable to retain the current rebound. Near-term pessimism took the form of a large-volume debit put spread in the May contract. It looks like one investor purchased 36,000 puts at the May $15 strike for a premium of $0.17 apiece, and sold the same number of puts at the lower May $14 strike for $0.07 each. The net cost of the trade amounts to $0.10 per contract, thus positioning the put player to pocket maximum potential profits of $0.90 per contract should shares decline 11.11% from the current price to breach the $14.00-level by expiration day. The trade is perhaps the work of an investor still smarting from last week’s market meltdown now taking advantage of relatively cheap downside protection today to hedge against similar catastrophic events. Bearishness spread to the June contract where another pessimistic individual enacted a put butterfly spread. The transaction involved the purchase of 10,000 now in-the-money puts at the June $16 strike for a premium of $0.67 each [wing 1] and the purchase of 10,000 puts at the lower June $14 strike for $0.23 apiece [wing 2]. The body of the butterfly, nestled between the two wings at the central June $15 strike, involved the sale of 20,000 puts for a premium of $0.41 each. The net cost of the butterfly spread amounts to just $0.08 per contract. The trade yields maximum potential profits of $0.92 per contract to the responsible party if shares of the XLF fall 4.75% from the current price to settle at $15.00 at June expiration. The investor starts to make money if shares of the financials ETF slip beneath the upper breakeven price of $15.92. Options traders exchanged more than 440,000 contracts on the…
continue reading


Tags: , , , , ,




Option Implied Volatility on JPM at Lowest Level Since Oct. 2007 Following Q4 Earnings

Today’s tickers: JPM, MNKD, CHK, BIDU, PFE, FXE, AA, SHFL, IBB & INTC

JPM – JPMorgan Chase & Co. – Profit-taking measures employed on the banking institution today show keen foresight by one investor who walked away from the table today with a nice chunk of change in his pocket. Shares of JPMorgan are currently trading 1.80% lower this afternoon to $43.89 even though the firm posted fourth-quarter earnings of $0.40 per share, which exceeded average analyst expectations by a margin of $0.13 a share. It looks like the investor banked gains on a previously established short put position in the February contract today by buying back the contracts at a discounted premium. The trader originally sold 20,000 puts at the February $42 strike for an average premium of $1.02 per contract this past Wednesday January 13, 2010. Today the same individual appears to have purchased-to-close the position by paying a lesser premium of $0.67 per contract. Net proceeds on the transaction amount to $0.35 apiece. The decline in shares of the underlying today certainly cut into the trader’s available profit, but the significant reduction in option implied volatility perhaps benefited the investor by weighing down option premiums. Option implied is 17.94% lower to stand at 25.13% – the lowest level since October of 2007 – as of 2:45 pm (EDT).

MNKD – MannKind Corp. – Shares of the biopharmaceutical company increased 7% in the first half of the trading day, but reversed direction in afternoon trading, falling 2.5% to stand at $10.10. Options activity in the May contract indicates lower volatility in the price of the underlying through expiration. It appears one investor initiated a short straddle play on the stock by selling 5,000 calls at the May $10 strike for a premium of $2.41 apiece, in combination with the sale of 5,000 puts at the same strike for $3.22 each. The straddle-seller pockets a gross premium of $5.63 per contract, which he keeps if MNKD’s shares settle at $10.00 by expiration. The transaction could be the work of an investor selling volatility. Implied volatility is currently up 8.4% to 122.16% with 90 minutes remaining in the session. The investor need not hold the short straddle through expiration in order to profit. Perhaps the trader is looking for a reduction in option implied volatility, which would likely result in lower premiums on both the calls and the puts. Lower…
continue reading


Tags: , , , , , , , , ,




Joy Global Options Active at the Close

Today’s tickers: JOYG, PRX, POT, IOC, QLGC, CAT & IBB

JOYG – Joy Global, Inc. – The manufacturer of mining equipment used to extract coal, copper, and other minerals, realized a 6% improvement in shares today to $55.13. Large-volume options trading took place just ahead of the closing bell as one investor banked gains and extended a bullish position on the stock. It appears the trader originally purchased 15,000 calls at the January 50 strike on August 4, 2009, for a premium of between 2.00 to 2.55 per contract. Today, he seems to have sold all 15,000 calls for 8.10 apiece. Net profits received on the closing sale amount to a minimum of 5.55 each up to a maximum of 6.10 per contract. Depending on the price the investor paid to initially purchase the calls, he reeled in at least $8,325,000, and could have banked as much as $9,150,000, by selling the now deep in-the-money call options today. Perhaps hoping to accumulate additional profits by expiration in January 2010, the trader doubled up on call options by purchasing 30,000 lots at the higher January 60 strike for an average premium of 3.30 per contract. The investor may add to his profits if shares rally another 15% to surpass the breakeven point at $63.30 by expiration day.

PRX – Par Pharmaceutical Companies, Inc. – The distributor of branded and generic pharmaceuticals in the U.S. appeared on our ‘hot by options volume’ market scanner due to bearish options trading. Shares of PRX fell more than 5% to $22.51 after receiving a downgrade to ‘neutral’ from ‘buy’ at Bank of America Merrill Lynch. One pessimistic option trader initiated a credit spread on PRX using call options in the November contract. The transaction involved the sale of 2,500 calls at the November 22.5 strike for 1.47 apiece, spread against the purchase of 2,500 calls at the higher November 25 strike for 55 cents each. The investor receives a net credit of approximately 92 cents per contract. The full 92 cent credit is retained by the trader as long as the November 22.5 strike call options land out-of-the-money by expiration.

POT – Potash Corporation of Saskatchewan, Inc. – Shares of Canada-based Potash Corp. surged more than 5.5% to $102.90 today on speculation that BHP Billiton Ltd. – the world’s largest mining company – may be interested in acquiring the fertilizer producer. Option traders exchanged…
continue reading


Tags: , , , , , ,




 
 
 

Phil's Favorites

The PhilStockWorld.com Weekly Trading Webinar - 11-20-19

For LIVE access on Wednesday afternoons, join us at Phil's Stock World – click here.

Major Topics:

00:01:48 Checking the Markets
00:06:30 Seeking Alpha News
00:10:43 Checking on Portfolios
00:12:49 Boarder Indexes
00:22:50 VIX
00:25:38 Portfolio Trade Ideas
00:38:03 SPX
00:47:12 LOW and HD
00:49:58 P/E HD
00:52:18 P/E Netflix
00:57:25 Portfolio Strategies
01:03:29 Macy's
01:07:47 Short-Term Portfolio
01:17:11 Checked back on the Markets

...



more from Ilene

Kimble Charting Solutions

Junk Bonds About To Send Stocks A Bearish Message?

Courtesy of Chris Kimble

Are junk bonds about to send stocks an important message? It looks like it from this chart!

Junk Bond ETF (JNK) has created a series of lower highs and lower lows over the past couple of years, inside of falling channel (1). When it broke support in early 2018 at (2), stocks struggled to make much upward progress for the next few months.

The rally off support last year saw JNK hit falling resistance a few months ago and some softness has set in. The small decline of late has it testing a series of higher lows at (3).

What JNK does at (3), looks to sen...



more from Kimble C.S.

Zero Hedge

Futures Spike To Session High On Report US May Delay Dec 15 Tariff Even If No Deal

Courtesy of ZeroHedge View original post here.

After sliding below 3,100 amid trade deal pessimism as recently as 9pm ET, futures have recovered all losses since the Reuters report that a trade deal may be delayed into 2020 after a report from Hong Kong's SCMP, which reported that while "hopes remain a watered-down deal can be reached before new US tariffs go into effect on December 15", but even if the deal proves elusive, "sources say it ...



more from Tyler

Insider Scoop

PayPal Will Buy Honey Science For $4B

Courtesy of Benzinga

PayPal Holdings Inc. (NASDAQ: PYPL) is acquiring Honey Science Corp for $4 billion.

Honey Science Corp was founded in 2012 and is headquartered in Los Angeles. Honey helps people automatically find online coupons and discounts while ...



http://www.insidercow.com/ more from Insider

Lee's Free Thinking

NY Department of Welfare Announces Increased Subsidies for Primary Dealers, Thank God!

 

NY Department of Welfare Announces Increased Subsidies for Primary Dealers, Thank God!

Courtesy of , Wall Street Examiner

Here’s today’s press release (11/14/19) from the NY Fed verbatim. They’ve announced that they will be making special holiday welfare payments to the Primary Dealers this Christmas season. I have highlighted the relevant text.

The Open Market Trading Desk (the Desk) at the Federal Reserve Bank of New York has released the schedule of repurchase agreement (repo)...



more from Lee

The Technical Traders

VIX Warns Of Imminent Market Correction

Courtesy of Technical Traders

The VIX is warning that a market peak may be setting up in the global markets and that investors should be cautious of the extremely low price in the VIX. These extremely low prices in the VIX are typically followed by some type of increased volatility in the markets.

The US Federal Reserve continues to push an easy money policy and has recently begun acquiring more dept allowing a deeper move towards a Quantitative Easing stance. This move, along with investor confidence in the US markets, has prompted early warning signs that the market has reached near extreme levels/peaks. 

Vix Value Drops Before Monthly Expiration

When the VIX falls to levels below 12~13, this typically v...



more from Tech. Traders

Biotech

Why telling people with diabetes to use Walmart insulin can be dangerous advice

Reminder: We are available to chat with Members, comments are found below each post.

 

Why telling people with diabetes to use Walmart insulin can be dangerous advice

A vial of insulin. Prices for the drug, crucial for those with diabetes, have soared in recent years. Oleksandr Nagaiets/Shutterstock.com

Courtesy of Jeffrey Bennett, Vanderbilt University

About 7.4 million people ...



more from Biotech

Chart School

Dow Jones cycle update and are we there yet?

Courtesy of Read the Ticker

Today the Dow and the SP500 are making new all time highs. However all long and strong bull markets end on a new all time high. Today no one knows how many new all time highs are to go, maybe 1 or 100+ more to go, who knows! So are we there yet?

readtheticker.com combine market tools from Richard Wyckoff, Jim Hurst and William Gann to understand and forecast price action. In concept terms (in order), demand and supply, market cycles, and time to price analysis. 

Cycle are excellent to understand the wider picture, after all markets do not move in a straight line and bear markets do follow bull markets. 



CHART 1: The Dow Jones Industrial average with the 900 period cycle.

A) Red Cycle:...

more from Chart School

Digital Currencies

Is Bitcoin a Macro Asset?

 

Is Bitcoin a Macro Asset?

Courtesy of 

As part of Coindesk’s popup podcast series centered around today’s Invest conference, I answered a few questions for Nolan Bauerly about Bitcoin from a wealth management perspective. I decided in December of 2017 that investing directly into crypto currencies was unnecessary and not a good use of a portfolio’s allocation slots. I remain in this posture today but I am openminded about how this may change in the future.

You can listen to this short exchange below:

...



more from Bitcoin

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>